Pharmax N.A., Inc. is a specialized manufacturing company, with a focus on pharmaceuticals, nutraceuticals, and cosmetics. Through its formulation division Nexatis, the company ensures the supply of high-quality products to the regulated market. With a strong emphasis on compliance, Pharmax N.A., Inc.'s regulatory team ensures adherence to global standards such as FDA and CEP. The company's approval as a supplier to industry giants like Pfizer, Zoetis, Novartis, and Phibro underscores its credibility and capability.
Moreover, its subsidiary testing laboratories, Rainbowlabs, have received approval from the U.S. FDA for quality control, guaranteeing the reliability and consistency of its products. With a founding date in 2000, Pharmax N.A., Inc. demonstrates a strong track record. The company’s mantra of sharpening competitiveness and providing product sourcing solutions positions them as a valuable player in the market. This presents an intriguing investment opportunity for venture capital firms seeking to tap into the pharmaceutical and manufacturing sectors.
There is no investment information
No recent news or press coverage available for Pharmax N.A., Inc..